PAM staining intensity of primary neuroendocrine neoplasms is a potential prognostic biomarker.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-68071-6

By:

• Horton, Timothy M.;
• Sundaram, Vandana;
• Lee, Christine Hye-Jin;
• Hornbacker, Kathleen;
• Van Vleck, Aidan;
• Benjamin, Kaisha N.;
• Zemek, Allison;
• Longacre, Teri A.;
• Kunz, Pamela L.;
• Annes, Justin P.

Publication type:

Article